Belts, Bags, and Medicines: Application of a Medical Treatment and Prevention Model for Automobile Occupant Protection

In that restraint systems can be viewed as medicines for the prevention of injury or death, some pharmacological approaches to the occupant restraint discussions are presented. Traffic morbidity and mortality are presented as endemic disease processes and pharmacological countermeasures in terms of testing dose rates, LD 50, side effects, informed consent and multiple drug usage, and federal drug approval are described.